SOPH
SOPHiA GENETICS SA [SOPH] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
SOPH Stock Summary
Top 10 Correlated ETFs
SOPH
Top 10 Correlated Stocks
SOPH
In the News
SOPH Financial details
Company Rating
-
Market Cap
326.51M
Income
-78.98M
Revenue
62.37M
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
430
Optionable
No
Shortable
Yes
Earnings
07 May 2024
P/E
-5.2
Forward P/E
-
PEG
5.05
P/S
6.1
P/B
2.26
P/C
-
P/FCF
-6.2
Quick Ratio
4.94
Current Ratio
5.3
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-1.22
EPS next Y
-
EPS next Q
-
EPS this Y
-10.29%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
18.15%
Revenue last 5Y
19.72%
Revenue Q/Q
4.57%
EPS Q/Q
76.19%
-
-
-
-
SMA20
-25%
SMA50
-
SMA100
-
Inst Own
-
Inst Trans
-
ROA
-33%
ROE
-39%
ROC
-0.4%
Gross Margin
69%
Oper. Margin
-121%
Profit Margin
-117%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
2.13-7.37
52W High
-56.57%
52W Low
+52%
RSI
40
Rel Volume
1.51
Avg Volume
56.65K
Volume
85.59K
Perf Week
-17.17%
Perf Month
-32.14%
Perf Quarter
-23.81%
Perf Half Y
-18.93%
-
-
-
-
Beta
1.175
-
-
Volatility
0.17%, 0.41%
Prev Close
-6.17%
Price
3.04
Change
-1.94%
Company Profile
- Volume Average 56.65K
- Market Capitalization 326.51M
- Employee 430
- CEO Dr. Jurgi Camblong M.B.A., Ph.D.
- Headquarters Saint-Sulpice,CH
- IPO Date 2021-07-23
-
Website
https://www.sophiagenetics.com 
SOPHiA GENETICS SA operates as a healthcare technology company. The company offers SOPHiA DDM platform, a cloud-based software-as-a-service platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities. Its SOPHiA DDM platform and related solutions, products, and services are used by hospital, laboratory, and biopharma worldwide. SOPHiA GENETICS SA was incorporated in 2011 and is headquartered in Saint-Sulpice, Switzerland.
